About us.

Senzagen is a spin out company from Lund University with expertice in immunology, technology and genomics. SenzaGen markets, sells and performs the in vitro GARD sensitization test through its own laboratory and through licenced CROs.

As a scientific quality-orientated and innovative international company, SenzaGen supports its clients with stringent quality assessments. The GARD test is recommended by ECHA and accepted by OECD for validation.

 Download Company information

SenzaGen makes it possible to replace animal experiments with in vitro genetic testing to determine the allergenicity of the chemicals we come into contact with in our daily lives, such as for example in cosmetics, pharmaceuticals, food products and dyes.

The company’s patented tests are the most reliable on the market and provide more information than traditional evaluation methods. We ourselves sell the tests in Sweden and the USA, and we sell through partners in several other countries. Over the next few years the company will expand geographically, make alliances with more distribution partners and launch further unique tests. SenzaGen has its headquarters in Lund in Sweden and a subsidiary in San Francisco, USA.